Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy.

Babu AF

Open source

DOI
10.3390/metabo16090659
Published
2026 Sep 8
Container
Metabolites
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/metabo16090659,
  title = {Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy.},
  author = {Babu AF},
  year = {2026},
  journal = {Metabolites},
  doi = {10.3390/metabo16090659},
  url = {https://doi.org/10.3390/metabo16090659}
}

RIS

TY  - JOUR
TI  - Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy.
AU  - Babu AF
PY  - 2026
JO  - Metabolites
DO  - 10.3390/metabo16090659
UR  - https://doi.org/10.3390/metabo16090659
ER  - 

APA

AF, B. (2026). Ketogenesis as a Metabolic Checkpoint in MASLD: Implications for Disease Progression and Therapy.. Metabolites. https://doi.org/10.3390/metabo16090659

Source records